Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.49
-0.07 (-0.52%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.10 billion as of April 25, 2025. Its market cap has increased by 4.01% in one year.
Market Cap
1.10B
Enterprise Value
405.58M
1-Year Change
4.01%
Ranking
Category
Stock Price
$13.49
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.10B, an increase of 3,070.16%. That is a compound annual growth rate of 37.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2025 | 1.10B | -27.24% |
Dec 31, 2024 | 1.52B | 32.59% |
Dec 29, 2023 | 1.15B | -2.59% |
Dec 30, 2022 | 1.18B | 173.74% |
Dec 31, 2021 | 429.50M | 567.96% |
Dec 31, 2020 | 64.30M | 320.26% |
Dec 31, 2019 | 15.30M | -83.62% |
Dec 31, 2018 | 93.40M | -59.86% |
Dec 29, 2017 | 232.70M | 6,363.89% |
Dec 30, 2016 | 3.60M | -55.00% |
Dec 31, 2015 | 8.00M | -16.67% |
Dec 31, 2014 | 9.60M | -72.33% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 743.12B |
UnitedHealth Group | 388.83B |
Johnson & Johnson | 380.15B |
AbbVie | 307.41B |
Novo Nordisk | 266.18B |
Abbott Laboratories | 228.46B |
Novartis AG | 211.63B |
AstraZeneca | 210.34B |